European Cancer Forum 2025: Innovation, Security and Sustainability
DUO-O trial: Durvalumab + Bevacizumab + Olaparib Improves PFS in Newly Diagnosed BRCA-Wild-Type Ovarian Cancer
10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily
Tanja Obradovic: Eventful 2025 Year for Cancer Drugs-45 New or Accelerated Approvals by FDA
CancerWorld Issue #110 (December) is Live
A New Invention: Nanoparticle-Based Salivary Biosensor for Early Detection of Oral Squamous Cell Carcinoma
Samra Turajlić: Honoured to Receive the 2026 Pezcoller–EACR Translational Cancer Award
Advancing Childhood Cancer Care at the 2025 St. Jude Global Alliance Convening
The Molecular Analysis for Precision Oncology (MAP) Congress 2026, co-organized by the European Society for Medical Oncology (ESMO), Cancer Research UK (CRUK), and Unicancer, is scheduled for 10–11 September 2026 […]
The ESMO Congress 2026 will take place from 23–27 October in Madrid, Spain, bringing together oncology professionals from around the world. This global event serves as a key platform for […]
The ESMO AI and Digital Oncology Congress 2026 will take place from November 16-18, 2026, in Berlin, Germany. This congress is designed as a central meeting point that facilitates the […]
The ESMO Immuno-Oncology Congress 2026 is a premier international event hosted by the European Society for Medical Oncology (ESMO), scheduled for December 14–16, 2026, as an onsite event in London, […]
The ESMO Congress 2027 will take place in Barcelona, Spain, from September 17–21, 2027. This event is recognized as a leading global oncology meeting that serves as a platform for […]